The role of multi-disciplinary teams in decision-making for patients with recurrent malignant disease

Abstract

Background: It is mandatory in many countries for decisions for all new patients with cancer to be made within multi-disciplinary teams (MDTs). Whether patients with disease recurrence should also routinely be discussed by the MDT is unknown. Aim: This study investigated the role of an upper gastro intestinal (UGI) MDT in decision-making for patients with disease recurrence. Design: A retrospective review of prospectively kept MDT records (2010 to 2011) was performed identifying patients discussed with recurrence of oesophagogastric cancer. Information was recorded about: i) why an MDT referral was made, ii) who made the referral and iii) the final MDT recommendation. Implementation of the MDT recommendation was also examined. Participants: All patients discussed with recurrence of cancer at a central UGI cancer MDT were included. Results: During the study 54 MDT meetings included discussions regarding 304 new patients and 29 with disease recurrence. Referrals to the MDT for patients with recurrence came from outpatient clinics ( n=19, 65.5%) or following emergency admission ( n=10). Most referrals were made by the surgical team ( n=25, 86.2%). MDT recommendations were best supportive care ( n=11, 37.9%), palliative chemotherapy ( n=9, 31.0%), stent ( n=5, 17.2%), palliative radiotherapy ( n=3, 10.3%) and further surgery ( n=1, 3.4%), with 25 (86.2%) of these implemented. Conclusion: UGI MDTs focus on new referrals and only a small proportion of patients with recurrent disease are re-discussed. Many patients go on to receive further treatments. Whether such patients are optimally managed within the standard MDT is uncertain, however, and warrants further consideration.